The Muscle-Bound Heart
| dc.contributor.author | Refaat, Marwan M. | |
| dc.contributor.author | Fahed, Akl C. | |
| dc.contributor.author | Hassanieh, Sylvana | |
| dc.contributor.author | Hotait, Mostafa | |
| dc.contributor.author | Arabi, Mariam Toufic | |
| dc.contributor.author | Skouri, Hadi N. | |
| dc.contributor.author | Seidman, Jonathan G. | |
| dc.contributor.author | Seidman, Christine E. | |
| dc.contributor.author | Bitar, Fadi Fouad | |
| dc.contributor.author | Nemer, Georges M. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Biochemistry and Molecular Genetics | |
| dc.contributor.department | Pediatrics and Adolescent Medicine | |
| dc.contributor.department | Cardiac Electrophysiology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:48:42Z | |
| dc.date.available | 2025-01-24T11:48:42Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Hypertrophic cardiomyopathy (HCM) is a familial cardiac disease manifested in a wide phenotype and diverse genotype and, thus, presenting unpredictable risks mainly on young adults. Extensive studies are being conducted to categorize patients and link phenotype with genotype for a better management and control of the disease with all its complications. Because the full mechanisms behind HCM are still not revealed, therapeutics are not definitive. Further research is to be conducted for the generation of a complete picture and directed therapy for HCM. © 2016 Elsevier Inc. | |
| dc.identifier.doi | https://doi.org/10.1016/j.ccep.2015.10.034 | |
| dc.identifier.eid | 2-s2.0-84959869801 | |
| dc.identifier.pmid | 26920199 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30836 | |
| dc.language.iso | en | |
| dc.publisher | W.B. Saunders | |
| dc.relation.ispartof | Cardiac Electrophysiology Clinics | |
| dc.source | Scopus | |
| dc.subject | Genotype | |
| dc.subject | Hypertrophic cardiomyopathy | |
| dc.subject | Left ventricle | |
| dc.subject | Muscle-bound heart | |
| dc.subject | Phenotype | |
| dc.subject | Adult | |
| dc.subject | Atrial fibrillation | |
| dc.subject | Cardiomyopathy, hypertrophic | |
| dc.subject | Catheter ablation | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Pedigree | |
| dc.subject | Antiarrhythmic agent | |
| dc.subject | Beta adrenergic receptor blocking agent | |
| dc.subject | Calcium channel blocking agent | |
| dc.subject | Diltiazem | |
| dc.subject | Disopyramide | |
| dc.subject | Diuretic agent | |
| dc.subject | Disease control | |
| dc.subject | Dyspnea | |
| dc.subject | Familial disease | |
| dc.subject | Genetic predisposition | |
| dc.subject | Genetic risk | |
| dc.subject | Genetic screening | |
| dc.subject | Genetic susceptibility | |
| dc.subject | Genetic variability | |
| dc.subject | Heart atrium flutter | |
| dc.subject | Heart left ventricle outflow tract obstruction | |
| dc.subject | Heart murmur | |
| dc.subject | Heart palpitation | |
| dc.subject | Human | |
| dc.subject | Hypertrophic nonobstructive cardiomyopathy | |
| dc.subject | Molecular pathology | |
| dc.subject | Priority journal | |
| dc.subject | Review | |
| dc.subject | Symptom | |
| dc.subject | Transthoracic echocardiography | |
| dc.subject | Case report | |
| dc.title | The Muscle-Bound Heart | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1